Skip to content
Get alerts
GovInfoNow
Lower risk Drug recall · FDA · Published July 6, 2020

Allergan Recalls Skin Medica Acne System Due to Subpotent Drug Content

Allergan recalls Skin Medica Acne System products that failed drug assay tests at 12 and 24 months, potentially containing insufficient salicylic acid and benzoyl peroxide.

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #D-1410-2020DrugAllergan ›
Take action

Contact the company

Recalling firmAllergan PLC2525 Dupont Dr · Irvine, CA 92612-1531
✎ GovInfoNow plain-language explainer

Allergan has recalled Skin Medica Acne System products that failed drug assay tests at 12 and 24 months. These products may contain insufficient salicylic acid and benzoyl peroxide, which could reduce effectiveness for acne treatment. Read more at govinfonow.com/recall/36957-allergan-recalls-skin-medica-acne-system-due-to-subpotent-drug.

Source Summary by GovInfoNow · govinfonow.com/recall/36957-allergan-recalls-skin-medica-acne-system-due-to-subpotent-drug · Updated October 5, 2026 · FDA enforcement record: FDA #D-1410-2020

Cite this page

“Allergan Recalls Skin Medica Acne System Due to Subpotent Drug Content.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/36957-allergan-recalls-skin-medica-acne-system-due-to-subpotent-drug. Based on FDA recall #D-1410-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1410-2020%22&limit=1).

Allergan PLC voluntarily recalled Skin Medica Acne System kits on July 6, 2020, after the FDA announced the products were subpotent. The Food and Drug Administration stated the recall was initiated by the firm due to failed assay results.

How to tell if you have it

  • Brand: Allergan
  • Product: Skin Medica Acne System
  • Components: Purifying Foaming Wash (Salicylic Acid 2.0%), 5 fl oz.; Purifying Toner (Salicylic Acid 2.0%), 6 fl oz; Acne Treatment Lotion (Benzoyl Peroxide 2.5%), 2 fl oz.
  • UPC: 300234966005
  • Lot codes: 090645A, 090645B, 090645C, 090757A, 093199A, 093199B, 093199C, 093199D, 096375A, 096375B, 097455A, 097612A
  • Expiration dates: 07/31/2020, 08/31/2020, 02/29/2020, 12/31/2020, 06/30/2021, 04/30/2021
  • Units affected: 8,555 kits

The hazard

The FDA reported that the Skin Medica Acne System products failed assay results at the 12 and 24 month timepoints. The recall classification is Class III.

Context

GovInfoNow's records show Allergan, PLC. has 7 other recalls on record since May 24, 2018. Recent Allergan recalls include Refresh Relieva Eye Drops and REFRESH Contact Lens Comfort Drops, both involving missing instructions for use in late December 2020. Other recent recalls of similar products include Bell Pharmaceuticals Clinere Carbamide Peroxide Recall (June 25, 2026), Sun Pharmaceutical Fluocinonide Cream Recall (March 25, 2026), and CoValence Laboratories Blemish Spot Treatment 1% Salicylic Acid Recall (April 1, 2026).

How to tell if you have this one

Check for lot numbers 090645A/B (exp. 07/31/2020), 090645C (exp. 08/31/2020), 090757A (exp. 02/29/2020), 093199A-D (exp. 12/31/2020), 096375A/B (exp. 06/30/2021), or 097455A/097612A (exp. 04/30/2021).

  • Brand
    Allergan
  • Product
    Allergan PLC recalls Skin Medica Acne System, Contains: Purifying Foaming Wash (Salicylic Acid 2.0%), 5 fl oz.; Purifying Toner (Salicylic
  • Category
    Drug
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class III
  • Status
    Terminated
  • Distribution
    Nationwide within the United States
Recall numberProduct, codes & lotsQuantity
D-1409-2020Skin Medica Acne Treatment Lotion (Benzoyl Peroxide 2.5%), 2 Oz bottle, Distributed in the U.S.A. by Allergan, Irvine, CA 92612, NDC 0023-4965-02; Lot #: 087293, Exp. Date 06/30/2020; 091356, Exp. Date 03/31/2021; Lot #: 093770, 093771, Exp. Date 07/31/20214,018 bottles
D-1410-2020Skin Medica Acne System, Contains: Purifying Foaming Wash (Salicylic Acid 2.0%), 5 fl oz.; Purifying Toner (Salicylic Acid 2.0%), 6 fl oz,; Acne Treatment Lotion (Benzoyl Peroxide 2.5%), 2 fl oz., Distributed in the U.S.A. by Allergan, Irvine, CA 92612, UPC 300234966005; Lot #: 090645A, 090645B, Exp. Date 07/31/2020; 090645C, Exp. Date 08/31/2020; Lot #: 090757A, Exp. Date 02/29/2020; Lot # 093199A, 093199B, 093199C, 093199D, Exp. Date 12/31/2020; Lot #: 096375A, 096375B, Exp. Date 06/30/2021; Lot #: 097455A, 097612A, Exp. Date 04/30/20218,555 kits
Based on the official FDA remedy

What to do — step by step

  1. Check Product Lot Number

    Look for lot numbers on the product packaging: 090645A, 090645B, 090645C, 090757A, 093199A-D, 096375A, 096375B, 097455A, or 097612A.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide within the United States” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 3.6 years after the firm started it.

1. Firm started the recall: Jul 6, 202012. FDA classified it Class III: Jul 27, 202023. Published in FDA’s Enforcement Report: Aug 5, 202034. FDA terminated the recall: Feb 28, 2024420202024
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

From the GovInfoNow team · based on the FDA notice · How we make summaries

Are there any safety risks from using this product?

The recall is due to potential reduced effectiveness, not safety risks. The products are safe to use but may not work as intended for acne treatment.

Similar recalls

Sun Pharmaceutical Fluocinonide Cream Recall: Failed Viscosity Testing
Sun Pharmaceutical IndustriesAmerican Health Packaging Recalls Metoclopramide Tablets Due to Foreign Drug Presence
American Health PackagingTeva Recalls Metoclopramide Tablets Due to Foreign Contaminants
Teva Pharmaceuticals USA, IncPreferred Pharma Recalls Lidocaine Ointment Due to Content Issues
Preferred Pharmaceuticals, Inc.Northstar Rx Recalls Tretinoin Cream Due to Impurities
SUN PHARMACEUTICAL INDUSTRIES INC

Latest drug recalls

Apothecary Pharma LLC recalls Tirzepatide Injection, 18mg/mL, 4 mL Sterile Multi-Dose Vial, Rx only, Apothecary Pharma, LLC, 1913 Evans Road, Cary,
Apothecary Pharma · September 24, 2026Apotex Corp. recalls Paroxetine Extended-Release Tablets, 37.5mg, 30-count bottle, Rx only, Manufactured by: Apotex Inc., Toronto, Ontario,
Apotex · September 23, 2026Cipla USA, Inc. recalls Fosfomycin Tromethamine Granules for Oral Solution, (Equivalent to 3 Grams of Fosfomycin), 1 Single-Dose Sachet, Rx
Cipla USA · September 18, 2026Ajanta Pharma USA Inc recalls Ranolazine Extended-Release Tablets, 1000 mg, 60-count bottle, Rx Only, Marketed by: Ajanta Pharma USA Inc.,
Ajanta Pharma · September 17, 2026Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company recalls Clear Eyes Redness Relief, Lubricant/Redness Reliever Eye Drops (glycerin 0.25%, naphazoline hydrochloride 0.012%) with
Insight Pharmaceuticals · September 15, 2026K.C. Pharmaceuticals, Inc. recalls Sterile Lubricant Dry Eye Relief Eye Drops, 0.5 FL OZ (15 mL); a) LEADER, DISTRIBUTED BY CARDINAL HEALTH, DUBLIN, OHIO
Leader / TopCare / Crocodile Tears · September 11, 2026

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1410-2020 (July 6, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1410-2020 to see it in context.
  • Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA